1. Revised recommendations for reducing the risk of human immunodeficiency virus transmission by blood and blood products Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, August 2020 Subject(s): Blood DonorsBlood TransfusionHIVHIV Infections -- prevention & controlUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Cancer clinical trial eligibility criteria: patients with HIV, hepatitis B Virus, or hepatitis C Virus Infections Publication: [Silver Spring, MD] : United States Food and Drug Administration, Oncology Center of Excellence, July 2020 Subject(s): Clinical Trials as TopicHepatitis BHepatitis CHIVNeoplasmsUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. One quarter of Medicaid enrollees with HIV may not have received critical services in 2021 Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, August 2023 Subject(s): Government RegulationHealth Services AccessibilityHealthcare DisparitiesHIVMedicaidUnited States
